BUCCASTEM

This brand name is authorized in New Zealand, United Kingdom

Active ingredients

The drug BUCCASTEM contains one active pharmaceutical ingredient (API):

1 Prochlorperazine
UNII I1T8O1JTL6 - PROCHLORPERAZINE MALEATE

Prochlorperazine belongs to the phenothiazine group. Prochlorperazine has a wide range of activity arising from its depressant actions on the CNS and its alpha-adrenergic blocking and weaker anti-muscarinic properties. It inhibits dopamine and prolactin-release-inhibitory factor, thus stimulating the release of prolactin.

Read about Prochlorperazine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
BUCCASTEM M Buccal tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N05AB04 Prochlorperazine N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AB Phenothiazines with piperazine structure
Discover more medicines within N05AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 14656
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 5186

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.